Figure 1 | Scientific Reports

Figure 1

From: Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis

Figure 1

Effects of oxaliplatin and lobaplatin on the growth of HCT‐116 and LOVO cells. (A, B) Oxaliplatin reduced CRC cells viability by the MTS assay. (C, D) Lobaplatin reduced CRC cells viability by the MTS assay. (E–J) Effects of oxaliplatin and lobaplatin on CRC cells colony formation. (K, L) Oxaliplatin and lobaplatin promoted the expression of Nrf2/HO-1 in overall protein and nuclear protein. Data are shown as the mean ± SD, *p < 0.05; **p < 0.01; ***p < 0.001.

Back to article page